On behalf of GPHL, Group chairman Li Chuyuan participated in the workshop entitled ‘Practices of Life and Health Education Innovation amid COVID-19’.
GPHL's project that strives to support Guizhou's roxburgh rose industry and develop Ciningji products was selected as one of the '50 Cases of National Best Practices for Targeted Poverty Alleviation'.
Chinese pharmaceutical giant Guangzhou Pharmaceutical Group has built two production bases in Meizhou city, Guangdong province, to help locals defeat poverty and boost economic development.
GPHL’s flagship products were displayed at the Xinhua News Agency’s national brand campaign pavilion, showing profound culture of traditional Chinese medicine (‘TCM’).
Construction completed and production commencing at Wanglaoji and Caizhilin production sites in Meiz
The construction of GPHL’s Wanglaoji Health Meizhou Stock Solution Extraction Complex and Caizhilin Meizhou TCM Industrialization Complex were completed and have commenced production.
The year, 2020, marks the 420th anniversary of the establishment of Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. (Chenliji) as well as its parent company, GPHL.
GPHL's subsidiary Guangzhou Pharmaceuticals Co., Ltd. was honoured with the title of ‘Outstanding Organization in Guangdong’s Fight Against COVID-19’.
It was also the only selected case from Guangdong and is GPHL's poverty alleviation project for vitalizing Guizhou's industry.
Chenliji Medicine Factory is the world's longest-lived medicine factory, a national intangible cultural heritage and the first Chenliji store since the founding of this time-honored brand.
"We launched the first marketing campaign across the Group, and Ciningji’s sales is expected to exceed 500 million RMB this year," Wu said.
GPHL chairman Li Chuyuan attended the Forum and delivered a keynote address to share GPHL's experience of participating in healthcare industry.